# BAG2

## Overview
BAG2 is a gene that encodes the protein BAG cochaperone 2, which plays a pivotal role in cellular protein homeostasis. As a co-chaperone, BAG cochaperone 2 interacts with the ATPase domain of heat shock protein 70 (Hsp70), facilitating the ADP/ATP exchange process and modulating Hsp70-client interactions. This interaction is crucial for the refolding of proteins and prevention of their aggregation, thereby maintaining cellular function and integrity (Qin2016BAG2). BAG cochaperone 2 is also involved in the ubiquitin-proteasome degradation system, where it inhibits the E3 ubiquitin ligase activity of CHIP, thus preventing protein ubiquitination and degradation (Qin2016BAG2). The protein is expressed in various human tissues and is implicated in several cellular processes, including stress signaling, cell division, and differentiation (Qin2016BAG2). Additionally, BAG cochaperone 2 has been associated with various cancers, where its overexpression correlates with poor prognosis and tumor progression (Huang2023BAG2; Yang2017Cochaperone).

## Structure
BAG2 is a protein composed of 211 amino acids, featuring a unique structure that includes several distinct domains. The C-terminal region of BAG2 contains the BNB (Brand New Bag) domain, which forms a novel dimeric structure distinct from other BAG domains. This domain is characterized by two long antiparallel helices connected by a disordered linker loop and a short helix, forming a 4-helix bundle with extensive hydrophobic packing (Xu2008Structural). The BNB domain plays a crucial role in nucleotide exchange and client binding, interacting with the Hsp70 nucleotide-binding domain (NBD) to promote nucleotide exchange (Xu2008Structural).

The N-terminal domain (NTD) of BAG2 also forms a dimer and is involved in higher-order oligomerization, contributing to the protein's ability to form tetramers and larger oligomeric species (Xu2008Structural). BAG2's structure allows it to bind multiple epitopes on a substrate, enhancing its chaperoning efficiency. BAG2 is phosphorylated at Ser20 by MAPK-activated protein kinase 2, which may regulate its interactions and function (Qin2016BAG2). The protein lacks a ubiquitin-like domain but contains a coiled-coil domain near the amino terminus, which is important for dimerization and interaction with other proteins (Arndt2005BAG2).

## Function
BAG2 (BAG cochaperone 2) is a protein that plays a crucial role in maintaining protein homeostasis in healthy human cells. It functions as a co-chaperone by interacting with the ATPase domain of heat shock protein 70 (Hsp70) through its BAG domain, influencing the ADP/ATP exchange process and regulating Hsp70-client interactions (Qin2016BAG2). This interaction is essential for the refolding of proteins and preventing their aggregation, thereby maintaining cellular function and preventing damage from misfolded proteins (Qin2016BAG2).

BAG2 is involved in the ubiquitin-proteasome degradation system, where it inhibits the E3 ubiquitin ligase activity of CHIP, associated with Hsp70. This inhibition helps in the refolding of proteins and prevents their ubiquitination and degradation through a ubiquitin-independent pathway (Qin2016BAG2). BAG2 is also phosphorylated by MAPKAP kinase 2, which may regulate its interaction with other proteins and its function in stress responses (Qin2016BAG2).

BAG2 is expressed in various human tissues, including brown adipose, heart, and lung tissues, and is involved in cellular processes such as stress signaling, cell division, cell death, and differentiation (Qin2016BAG2).

## Clinical Significance
BAG2 (BAG cochaperone 2) is implicated in various cancers, where its overexpression is associated with poor prognosis and tumor progression. In triple-negative breast cancer (TNBC), BAG2 is overexpressed and correlates with poor clinical outcomes, including reduced survival rates and increased metastasis risk (Yang2017Cochaperone). BAG2 also contributes to chemoresistance in breast cancer by promoting mutant p53 aggregates, which are linked to aggressive cancer features and poor survival (Huang2023BAG2).

In hepatocellular carcinoma (HCC), BAG2 is upregulated and associated with worse clinicopathological features, such as advanced tumor stage and vascular invasion. High BAG2 expression correlates with shorter survival, suggesting its role as an oncogene (Zhang2021Bcl2). Similarly, in gastric cancer, BAG2 promotes proliferation and metastasis through the ERK1/2 signaling pathway, with high expression linked to poor prognosis (Sun2020BAG2).

BAG2's interaction with mutant p53 proteins is crucial in tumorigenesis, as it inhibits the degradation of these proteins, leading to their accumulation and enhanced oncogenic functions (Yue2015BAG2). This interaction is significant in various cancers, including colorectal and lung cancers, where BAG2 overexpression is linked to poor survival outcomes (Yue2015BAG2).

## Interactions
BAG2 interacts with several proteins, primarily through its role in protein homeostasis and degradation pathways. It binds to the ATPase domain of heat shock protein 70 (Hsp70) via its BAG domain, modulating Hsp70-mediated chaperone activity and inhibiting the Hsp70-associated ubiquitin ligase CHIP. BAG2 acts as an efficient and specific inhibitor of CHIP-dependent ubiquitin ligase activity by disrupting CHIP/E2 cooperation, which is crucial for ubiquitination processes (Xu2008Structural; Qin2016BAG2).

BAG2 also interacts with Hsc70, promoting nucleotide exchange and facilitating protein refolding. Specific residues in BAG2, such as Ile160 and Gln167, are crucial for its interaction with Hsc70's nucleotide-binding domain (Xu2008Structural). BAG2's interaction with Hsp90 is required for ERK1/2 activation, and it can reverse nicotine-induced tau phosphorylation, potentially through its association with Hsp90 or through BAG2-mediated degradation of phosphorylated tau (Qin2016BAG2).

In the context of autophagy, BAG2 interacts with ULK1, AMBRA1, and CLCC1, influencing autophagy initiation and vesicle trafficking. These interactions are modulated by phosphorylation and subcellular localization changes, particularly under nutrient starvation conditions (Siva2023The). BAG2 also interacts with mutant p53 proteins, inhibiting their degradation and promoting their accumulation, which is significant for the gain-of-function effects of mutant p53 in cancer (Yue2015BAG2).


## References


[1. (Sun2020BAG2) Lisha Sun, Guanglei Chen, Anqi Sun, Zheng Wang, Haibo Huang, Ziming Gao, Weitian Liang, Caigang Liu, and Kai Li. Bag2 promotes proliferation and metastasis of gastric cancer via erk1/2 signaling and partially regulated by mir186. Frontiers in Oncology, January 2020. URL: http://dx.doi.org/10.3389/fonc.2020.00031, doi:10.3389/fonc.2020.00031. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2020.00031)

[2. (Xu2008Structural) Zhen Xu, Richard C Page, Michelle M Gomes, Ekta Kohli, Jay C Nix, Andrew B Herr, Cam Patterson, and Saurav Misra. Structural basis of nucleotide exchange and client binding by the hsp70 cochaperone bag2. Nature Structural &amp; Molecular Biology, 15(12):1309–1317, November 2008. URL: http://dx.doi.org/10.1038/nsmb.1518, doi:10.1038/nsmb.1518. This article has 77 citations.](https://doi.org/10.1038/nsmb.1518)

[3. (Zhang2021Bcl2) Xi Zhang, Junjun Zhang, Yang Liu, Jie Li, Juan Tan, and Zewen Song. Bcl-2 associated athanogene 2 (bag2) is associated with progression and prognosis of hepatocellular carcinoma: a bioinformatics-based analysis. Pathology and Oncology Research, April 2021. URL: http://dx.doi.org/10.3389/pore.2021.594649, doi:10.3389/pore.2021.594649. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/pore.2021.594649)

[4. (Yue2015BAG2) Xuetian Yue, Yuhan Zhao, Juan Liu, Cen Zhang, Haiyang Yu, Jiabei Wang, Tongsen Zheng, Lianxin Liu, Jun Li, Zhaohui Feng, and Wenwei Hu. Bag2 promotes tumorigenesis through enhancing mutant p53 protein levels and function. eLife, August 2015. URL: http://dx.doi.org/10.7554/elife.08401, doi:10.7554/elife.08401. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.08401)

[5. (Qin2016BAG2) Lixia Qin, Jifeng Guo, Qian Zheng, and Hainan Zhang. Bag2 structure, function and involvement in disease. Cellular &amp; Molecular Biology Letters, September 2016. URL: http://dx.doi.org/10.1186/s11658-016-0020-2, doi:10.1186/s11658-016-0020-2. This article has 57 citations.](https://doi.org/10.1186/s11658-016-0020-2)

[6. (Arndt2005BAG2) Verena Arndt, Christina Daniel, Wolfgang Nastainczyk, Simon Alberti, and Jörg Höhfeld. Bag-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase chip. Molecular Biology of the Cell, 16(12):5891–5900, December 2005. URL: http://dx.doi.org/10.1091/mbc.E05-07-0660, doi:10.1091/mbc.e05-07-0660. This article has 249 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E05-07-0660)

[7. (Huang2023BAG2) Xinjian Huang, Dongni Shi, Xuxiazi Zou, Xuxia Wu, Shumei Huang, Lingzhi Kong, Muwen Yang, Yunyun Xiao, Boyu Chen, Xiangfu Chen, Ying Ouyang, Libing Song, Yunting Jian, and Chuyong Lin. Bag2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate. Theranostics, 13(1):339–354, 2023. URL: http://dx.doi.org/10.7150/thno.78492, doi:10.7150/thno.78492. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7150/thno.78492)

[8. (Yang2017Cochaperone) Kyung-Min Yang, Eunjin Bae, Sung Gwe Ahn, Kyoungwha Pang, Yuna Park, Jinah Park, Jihee Lee, Akira Ooshima, Bora Park, Junil Kim, Yunshin Jung, Satoru Takahashi, Joon Jeong, Seok Hee Park, and Seong-Jin Kim. Co-chaperone bag2 determines the pro-oncogenic role of cathepsin b in triple-negative breast cancer cells. Cell Reports, 21(10):2952–2964, December 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.11.026, doi:10.1016/j.celrep.2017.11.026. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.11.026)

9. (Siva2023The) The ULK1 effector BAG2 regulates autophagy initiation by modulating AMBRA1 localization. This article has 0 citations.